mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0004 |
mRNA |
Vorinostat |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0004 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0004 |
mRNA |
AZD6244 |
CCLE |
pan-cancer |
AAC |
-0.16 |
0.0005 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0005 |
mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
0.0006 |
mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0007 |
mRNA |
dinaciclib |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.0007 |